Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Haematologica|December 24, 2013
Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapyGabriel Etienne, Stéphanie Dulucq, Franck-Emmanuel Nicolini, et al.
Oncogene|January 12, 2018
AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancerDaniela Welcker, Manaswita Jain, Safiya Khurshid, et al.
Cancer Medicine|July 28, 2019
Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitorsGabriel Etienne, Stéphanie Dulucq, Françoise Huguet, et al.
Molecular Cancer Therapeutics|March 5, 2022
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 HeterodimerizationLisa Werr, Dennis Plenker, Marcel A Dammert, et al.
Cancers|September 9, 2020
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML PatientsGabriel Etienne, Stéphanie Dulucq, Fréderic Bauduer, et al.
The Lancet. Oncology|October 9, 2020
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trialFranck Morschhauser, Hervé Tilly, Aristeidis Chaidos, et al.
Blood Advances|June 30, 2022
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network studyPaul Lesueur, Gandhi Damaj, Khê Hoang-Xuan, et al.
Radiology. Imaging Cancer|September 19, 2025
Automatic Segmentation of Primary Central Nervous System Lymphoma at Clinical Routine Postcontrast T1-weighted MRIGuanghui Fu, Lucia Nichelli, Darío Herrán de la Gala, et al.
Cancer Medicine|May 14, 2021
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitorsGabriel Etienne, Carole Faberes, Fréderic Bauduer, et al.
Cancer Research|May 20, 2018
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung CancerLydia Meder, Philipp Schuldt, Martin Thelen, et al.
Pageof 6